Off-the-shelf vaccine shows promise in preventing cancers returning, study finds

Non-mRNA jab targeting common mutations in pancreatic and bowel cancers could lower risk of relapse

An off-the-shelf vaccine has shown promise in preventing the return of pancreatic and colorectal cancer, researchers have revealed.

Cancer vaccines have been the subject of promising research in recent years. The NHS in England has been trialling various jabs in patients through the Cancer Vaccine Launch Pad (CVLP).